The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

From lab to patient – the art of developing new antibody therapies

For 25 years, Danish company Genmab has been developing antibodies and has managed to get several drugs all the way to the patient. Esther Breij has been along ...

FDA godkänner första icke-opioida smärtstillaren på över 20 år

För första gången på flera decennier har en ny typ av läkemedel mot akut smärta som inte är en opioid godkänts i USA.

From powder to implant

Quality assurance for additively manufactured implants.

Compact and leak-tight powerhouse

Media-separated solenoid valve VYKA from Festo is virtually leak-free

Mikael Kubista tillbaka med ny satsning – efter turbulenta avskedet

Entreprenören och forskaren Mikael Kubista startar ett nytt bolag. Nu är han också fri att kommentera händelseförloppet som ledde till att han förlorade ägandet...

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

Mastering Urine Microscopy

On-demand Webinar: Microscopy in urinalysis.

Government apoints new experts to medicine and health council

Johanna Fälting, Head of Research at BioArctic, and physician Markus Lingman have been appointed as new members of the Swedish Research Council’s Subject Counci...

Quality Assurance for the Highest Medical Standards

Metrology Solutions for Medical Components.

Automated nitrogen analysis reduces costs per sample

N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo

Utredningarna mot Astra Zeneca: ”Kinesiska intressen kan ligga bakom”

Varför pågår det flera utredningar mot Astra Zeneca-anställda i Kina just nu? Life Science Sweden fortsätter att nysta i härvan.

He takes over the chairmanship of Karolinska Development

Ben Toogood is appointed as the new chairman of Karolinska Developments.

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.

Trender inom life science 2025 – Del 1 fetmaläkemedel

Fler fetmapreparat är på väg efter Novo Nordisks och Eli Lillys framgångar med GLP-1-läkemedel. Men nästa stora genombrott inom obesitas har en annan verkningsm...

The Future of Swedish & Danish Life Science 2026

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

SupraCube - In life Science

Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...

Anna Törner: Yes, I Am Sick, But Not Weak

”People often say that someone who is ill only has one wish—to get better. But I think that is not true. Someone who is ill also longs to be understood, to be r...

Japanese pharma to buy US drugmaker for $2.4 bln

Japanese Ono Pharmaceutical buys the American cancer drug developer Deciphera Pharmaceuticals in one of the largest acquisitions in the industry so far this year.

Takeover bid is being completed – Japanese company acquires Calliditas

Japanese company Asahi Kasei completes the bid for Calliditas Therapeutics after reaching over 90 percent of the shareholding. Callidita's board has now decided...

Ingrid Lönnstedt: ”The confidence interval and its width”

Always keep an eye on the width of your and others’ confidence intervals, writes Ingrid Lönnstedt in a science column.

Doge backar om nedläggning av viktigt FDA-labb

Trumpadministrationen drar efter kritik tillbaka beslutet att stänga ett av FDA:s viktigaste laboratorier för läkemedelskontroll.